The aim of this study was to assess incidence of cardiac events and/or left ventricular (LV) dysfunction in athletes exposed to strenuous and uninterrupted training for extended periods of time.
Background
Whether highly intensive and uninterrupted athletic conditioning over a long period of time might be responsible for cardiac events and/or LV dysfunction is unresolved.
Methods
We assessed clinical profile and cardiac dimensions and function in 114 Olympic athletes (78% male; mean age 22 Ϯ 4 years), free of cardiovascular disease, participating in endurance disciplines, who experienced particularly intensive and uninterrupted training for 2 to 5 consecutive Olympic Games (total, 344 Olympic events), over a 4-to 17-year-period (mean 8.6 Ϯ 3 years).
Results
Over the extended period of training and competition, no cardiac events or new diagnoses of cardiomyopathies occurred in the 114 Olympic athletes. Global LV systolic function was unchanged (ejection fraction: 62 Ϯ 5% to 63 Ϯ 5%; p ϭ NS), and wall motion abnormalities were absent. In addition, LV volumes (142 Ϯ 26 ml to 144 Ϯ 25 ml; p ϭ 0.52) and LV mass index (109 Ϯ 21 g/m 2 to 110 Ϯ 22 g/m 2 ; p ϭ 0.74) were unchanged, and LV filling patterns remained within normal limits, although left atrial dimension showed a mild increase (37.8 Ϯ 3.7 mm to 38.9 Ϯ 3.2 mm; p Ͻ 0.001).
Conclusions
In young Olympic athletes, extreme and uninterrupted endurance training over long periods of time (up to 17 years) was not associated with deterioration in LV function, significant changes in LV morphology, or occurrence of cardiovascular symptoms or events. The long-term clinical consequences of cardiac remodeling in trained athletes and whether chronic exposure to highly intensive athletic conditioning might ultimately be responsible for abnormal cardiac function and/or adverse events are not completely resolved. Occurrence of "cardiac fatigue" with acute and transient left ventricular (LV) systolic dysfunction and segmental wall motion abnormalities have been reported as an effect of prolonged endurance events lasting 3 to 17 h-such as Iron-man triathlon races (1-4)-suggesting that athletic training, when particularly strenuous, might be responsible for deterioration in LV function. We have previously shown persistent LV cavity enlargement after prolonged deconditioning in former elite athletes (5) , and other investigators have reported LV dysfunction in professional bicyclists of middle-age (6) . Indeed, more than 10% of elite cyclists participating in serial Tour de France races unexpectedly showed systolic dysfunction with marked See page 1626 LV cavity dilation, suggesting a possible diagnosis of dilated cardiomyopathy (7) . More recently, ominous ventricular tachyarrhythmias of right ventricular originassociated with mild reduction in systolic function-have been reported in highly trained cyclists (8) , suggesting that excessive physical training might have adverse electrophysiologic consequences.
To address this important clinical issue, we have taken the opportunity to assess a unique population of Olympic athletes, who had been exposed to strenuous and uninterrupted training for extended periods of time, including participation in up to 5 consecutive Olympic Games.
Methods
Study population. The Institute of Sports Medicine and Science in Rome is a medical division of the Italian National Olympic Committee, responsible for the physiologic and medical evaluation of elite athletes who are members of the national teams, from which the participants in the Olympic Games are selected every 4 years. The medical program for Olympic athletes routinely includes cardiovascular evaluation with history, physical examination, 12-lead and exercise electrocardiography (ECG), and 2-dimensional and Doppler echocardiography (9) .
For the purpose of this investigation, we selected elite athletes engaged in those endurance sports known to be associated with the most substantial cardiac remodeling (10, 11) , who had been training uninterruptedly at the highest competitive level in at least 2 consecutive Summer or Winter Olympic Games from 1992 or 1994, respectively, and in the World Championships in the alternate years.
Of the 9,630 athletes evaluated from 1992 to 2008 in our Institute, 2,330 were examined within the Olympic program; from this population, 460 Italian athletes participating in particularly intense endurance sports disciplines (i.e., cycling, long-distance running, cross-country skiing, swimming, rowing/canoeing, triathlon) were considered for inclusion in the study. Among these 460 athletes, 114 had participated in 2 or more consecutive Olympic Games and had technically satisfactory echocardiograms and therefore were selected for the final study population.
These 114 Italian athletes (89 male and 25 female), age 22 Ϯ 4 years at the study entry and with mean body surface area (BSA) of 1.9 Ϯ 0.2 m 2 , were engaged in rowing/ canoeing (n ϭ 55), cycling (n ϭ 19), middle-distance running (800 m; 3,000 m steeple-chase; and 5,000 m; n ϭ 8), long-distance running (10,000 m and marathon; n ϭ 9), cross-country skiing (n ϭ 15), swimming (400 to 1,500 m; n ϭ 6), and triathlon (n ϭ 2). Before their initial Olympic team selection, the 114 athletes had been involved in regular endurance training and competition at the national level for a period of 1 to 15 years (mean 6.9 Ϯ 3.8 years) and, after Olympic selection, trained uninterruptedly for an additional 4 to 17 years (mean 8.6 Ϯ 3.7 years), for a total training period of 15.5 Ϯ 4.1 years. Training schedules in the pre-Olympic phase usually included 2 daily sessions, each of Ն2-h duration, including specific work (e.g., on boat for rowers/canoeists, on track for runners) and technical aspects and/or general muscle conditioning programs (see detailed training schedule in Online Appendix).
The period of observation extended from the time each athlete underwent our evaluation before first participation in the Olympic Games to the time the athlete participated in the most recent Olympics (or World Championships). The average time duration between these 2 examinations was 8.6 Ϯ 3.7 years (range 4 to 17 years).
Each subject included in this analysis was judged to be free of structural cardiovascular disease at initial evaluation on the basis of medical history, physical examination (with blood pressure consistently Ͻ140/90 mm Hg), exercise ECG testing, and 2-dimensional and Doppler echocardiography. In athletes with LV wall thickness exceeding normal limits (Ն13 mm) and/or markedly dilated LV cavity (Ն60 mm), physiologic remodeling of the athlete's heart was distinguished from hypertrophic cardiomyopathy and dilated cardiomyopathy, respectively, according to previously described criteria (11) (12) (13) (14) . Six athletes presented markedly abnormal repolarization patterns on ECG, with inverted T waves of Ͼ2 mm in Ͼ2 precordial/standard leads in the absence of structural cardiac disease (15) . Comparison group. To exclude the possibility that changes in cardiac function could have precluded athletes not included in our study group from continued participation in consecutive Olympic Games; we assembled a comparison group of elite athletes engaged in endurance sports on the basis of these criteria: 1) participation in only 1 Olympic Games; and 2) subsequent 4-year period during which systematic training continued but the athletes failed to be selected as members of Italian teams for the subsequent Olympic Games.
From our database of athletes engaged in endurance sports, who were examined within our Olympic program from 1992 to 2000, we identified 97 who met these criteria. These athletes were comparable to the study group of the 114 with regard to age (23.5 Ϯ 4.1 years vs. 22.1 Ϯ 3.8 years) and type of sport participated in (73% vs. 78% engaged in rowing/canoeing, cycling, and long-distance running). Echocardiography. Two-dimensional and Doppler echocardiographic studies were performed with commercially available Philips Sonos 1500 or Sonos 5500 (Philips Medical System, Bothell, Washington) instruments. Images of the heart were obtained in multiple cross-sectional planes by using standard transducer positions. M-mode echocardiograms were derived from 2-dimensional images under direct anatomic visualization and were recorded at 100 mm/s. Measurements of end-diastolic and end-systolic LV cavity dimensions and anterior ventricular septal and posterior free wall thicknesses were obtained in accordance with recommendations of the American Society of Echocardiography (16, 17) . The LV mass was calculated with the formula proposed by Devereux et al. (18) and was indexed to BSA. Relative wall thickness was the ratio of the average ventric- ular septal and posterior free wall thickness to the radius of the ventricular cavity. Ejection fraction was assessed from end-diastolic and -systolic LV volumes, in the apical 4-chamber view and quantified according to modified Simpson rule (19) . In addition, the blood pressure/end-systolic volume index ratio was used to characterize LV systolic function (20) . Parameters of LV filling were obtained with pulsed Doppler echocardiography, as previously described (21) .
This study was funded by the Italian National Olympic Committee and the design was approved by the institutional review board. Written informed consent was waived for all athletes undergoing a standard clinical evaluation pursuant to Italian law and institute policy. All the records and clinical data on these athletes are kept in a database maintained by the Institute. Statistical analysis. Data were expressed as mean Ϯ SD. Differences between means were assessed with paired or unpaired Student t test, as appropriate. Differences between proportions were assessed with chi-square test. A 2-tailed p value Ͻ0.05 was considered evidence of statistical significance. Statistical analyses were carried out with the BMDP Statistical software (22) .
Results
Athlete's career. Of the 114 athletes included in this investigation, 42 had participated in 2 consecutive Olympic Games, 40 athletes in 3 Olympics, 20 athletes in 4 Olympics, and 12 athletes in 5 Games. Overall, the athletes in this study participated in 344 Olympic Games and 862 World Championships, and 42 (37%) had been medalists 1 or more times. Cardiac functional changes. Echocardiographic-derived indexes of LV function are reported in Table 1 . Global systolic function did not change over time (ejection fraction: 62 Ϯ 5% to 63 Ϯ 5%; p ϭ 0.09), and no athlete showed decreased LV systolic function (i.e., ejection fraction Ͻ50%) or regional wall motion abnormalities at most recent evaluation. The blood pressure/systolic volume index ratio was within normal limits in each athlete and did not change over the period of observation (4.09 Ϯ 0.9 to 4.31 Ϯ 1.1; p ϭ 0.32).
Doppler-derived late diastolic (atrial) peak A-wave velocity increased during the follow-up (32.3 Ϯ 10.0 cm/s to 42.3 Ϯ 9.4 cm/s; ϩ31%; p Ͻ 0.001), and early diastolic peak E-wave velocity did not change. Therefore, the E/A ratio decreased (2.5 Ϯ 0.7 to 1.8 Ϯ 0.4; Ϫ28%; p Ͻ 0.001). However, at the most recent evaluation each athlete showed a normal filling pattern (with E/A Ͼ1). Deceleration time increased during the observation period from 165 Ϯ 33 to 193 Ϯ 39 (p Ͻ 0.05). Cardiac dimensional changes. Cardiac dimensions in Olympic athletes at initial and most recent evaluation are reported in Table 2 . No significant changes (by paired t test) were observed for LV cavity dimensions, wall thickness, relative wall thickness, or mass index over the long-term period of training and competition (Fig. 1) Values are reported as mean Ϯ SD (range). Statistical differences assessed by paired t test and by chi-square test for proportions.
DT ϭ deceleration time; E/A ratio ϭ early-to-late diastolic peak flow velocity ratio; EFϭ ejection fraction; E slope ϭ early diastolic peak flow velocity deceleration rate; FSϭ fractional shortening; peak A ϭ late (atrial) diastolic peak flow velocity; peak E ϭ early diastolic peak flow velocity; LV ϭ left ventricular; PSP/ESVi ϭ ratio of the peak systolic pressure/end-systolic volume index.
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Clinical Consequences of Intense Athletic Training significant dimensional increase was found for left atrial dimensions in both men (38.6 Ϯ 3.5 mm to 39.6 Ϯ 2.9 mm; ϩ3%; p Ͻ 0.01) and women (34.7 Ϯ 2.6 mm to 36.6 Ϯ 3.0 mm; ϩ5%; p Ͻ 0.007). Mild increase of the aortic root dimension was observed in men (33.3 Ϯ 2.1 mm to 34.0 Ϯ 2.7 mm; ϩ2%; p Ͻ 0.01) but not in women (p ϭ 0.70). Clinical findings. In the overall population of Olympic athletes, no cardiovascular symptoms or events occurred during the extended period of training and competition, and each performed exercise testing to Ն85% of predicted maximum heart rate without symptoms at the most recent evaluation. None of the athletes with abnormal repolarization patterns showed either clinical or morphologic evidence of cardiac disease. However, 5 athletes had abnormal clinical findings, specified here. Two of these athletes had ventricular tachyarrhythmias observed at initial evaluation, including frequent premature ventricular beats with left bundle branch block pattern, 1 couplet, and 1 burst of nonsustained ventricular tachycardia (4 beats with R-R interval of 250 ms) observed on exercise testing in 1; and rare premature ventricular beats, rare couplets, and 1 short run of nonsustained ventricular tachycardia (3 beats with R-R interval 450 ms) recorded on 24-h ambulatory (Holter) ECG in the other. Echocardiography and cardiovascular magnetic resonance were negative for structural or functional cardiac abnormalities. The first, a 33-year-old male rower, who participated in 3 consecutive Olympic Games, remained asymptomatic and without recurrence of arrhythmias after successful radiofrequency ablation. The latter, a 32-year-old male cross-country skier, who participated in 2 consecutive Olympic Games, showed disappearance of the ventricular arrhythmias over the follow-up while undergoing periodical evaluations in our institute.
Three other athletes, including a 35-year-old male marathon runner, a 28-year-old male rower, and a 32-year-old female skier, showed T-wave inversion and Ն2-mm STsegment depression on routine exercise ECG, at workloads of Ն300 watts, in the absence of cardiac symptoms. Presence of anomalous origin or course of coronary arteries and atherosclerotic coronary artery disease were excluded by computed tomography scan and/or coronary angiography and morphologic cardiac abnormalities by echocardiography and/or cardiovascular magnetic resonance. These 3 athletes were eventually cleared for competition and have remained asymptomatic over the follow-up period encompassing Ն2 Olympic Games. Comparison group. Demographic and cardiac dimensional and functional characteristics of the 97 athletes comprising the comparison group, who participated in 1 Olympic Games, trained over the subsequent 4 years, but eventually were not selected for the next Olympic Games, are reported in 
63 Ϯ 6% to 64 Ϯ 6%; p ϭ 0.39), blood pressure/systolic volume index ratio, or LV filling pattern as assessed by transmitral Doppler echocardiography.
Discussion
The long-term clinical consequences of cardiac remodeling in athletes have periodically been questioned and remain largely unresolved. Most studies describing cardiac remodeling in elite athletes have been cross-sectional in design and underpowered to clarify the clinical implications and longterm consequences of the "athlete's heart" (10, 11, (23) (24) (25) (26) (27) (28) . In the present study we have addressed this question, by assessing a unique population of highly trained, particularly elite, and largely world-class athletes, who had been engaged in endurance training and competition at the highest level uninterruptedly for more than 8 years on average, Values are reported as mean Ϯ SD (range). A wave ϭ peak late (atrial) diastolic filling velocity; AVS ϭ anterior ventricular septum; BSA ϭ body surface area; E wave ϭ peak early diastolic filling velocity; EF ϭ ejection fraction; LA ϭ left atrium; LV ϭ left ventricular; LVDd ϭ left ventricular end-diastolic diameter; LVM index ϭ left ventricular mass normalized to body surface area; PFW ϭ posterior free wall; SBP/ESV ϭ ratio of systolic blood pressure to normalized end-systolic volume.
including participation in up to 5 consecutive Olympic Games. We regarded this unique athletic population, comprising top competitors in endurance disciplines (known to be associated with the most marked cardiac remodeling) (10, 11) , as an appropriate model to assess the possibility of adverse cardiovascular consequences of a particularly intensive and chronic exercise training.
The most important finding of our study was the demonstration that, despite exposure to the most vigorous training schedule required to compete at the highest (i.e., Olympic) level, prolonged for an substantial period of time, no cardiovascular events occurred; nor was deterioration in global LV systolic function or wall motion abnormalities evident in these athletes. Furthermore, we did not observe changes in LV systolic function or incidence of cardiovascular abnormalities in our comparison group of athletes who competed in 1 Olympic Games but failed to qualify for the subsequent Games 4 years later.
Therefore, contrary to a previous investigation showing LV dysfunction in professional cyclists participating in Tour de France races (7), our data show that strenuous and chronic exercise training is not responsible, per se, for deterioration of LV systolic function in healthy athletes. Furthermore, we believe that the systematic anti-doping policy implemented in recent years had a major impact in preventing potential harmful effects of doping, including possible LV dysfunction. Definitely, the Italian Olympic athletes included in this study had been cleared at serial doping controls in the periods preceding and during the Olympic Games. Finally, despite certain morphologic similarities of cardiac remodeling between our chronically trained athletes and patients with dilated cardiomyopathies, none of our athletes with marked LV cavity enlargement experienced cardiac symptoms or impaired physical performance over the long-term observation period of up to 17 years (15) .
As an incidental finding, we observed a modest (although statistically significant) increase in left atrial dimension in our athletes. This finding was not entirely unexpected, because we have previously reported enlargement of the left atrium as an effect of long-term, intensive training in competitive athletes (28) . Such atrial remodeling as well as LV cavity enlargement likely represents a physiologic adaptation to increased preload associated with chronic exercise and ultimately a mechanism by which LV filling is normal in trained athletes. Indeed, the physiologic nature of the atrial enlargement is underscored by the preserved systolic emptying (shown by normal Doppler-flow pattern) and the absence of atrial arrhythmias. However, given the youthful age of our athletes at most recent assessment, we cannot exclude the possibility that enlargement of the left atrium might be of clinical relevance over the long-term period and when athletes achieve more advanced age.
We wish to underscore that the population of elite athletes who comprise the present investigation is unique by virtue of their particularly prolonged and successful commitment to an intensive training schedule over many years. Because of the very select nature of this subset of athletes, however, results derived from the present investigation might not be directly comparable to the natural course of cardiac functional changes in all competitive athletes undergoing chronic and intensive conditioning.
In conclusion, this study of uniquely trained Olympic athletes shows that intensive conditioning over many years was not associated with inappropriate LV remodeling or dysfunction or with adverse clinical events, onset of symptoms, or new diagnosis of cardiomyopathies. Our findings support the benign nature of physiologic heart remodeling in trained athletes and the safety of long-term and intense sports participation, even at the highest competitive level.
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